Subject has been maintained on a stable dose of levetiracetam LEV and a sodium channel blocking antiepileptic drug SCB-AED for at least 4 weeks prior to the Screening Visit Visit 1 and during the 4-week Prospective Seizure Baseline with or without additional concurrent stable vagal nerve stimulation VNS The VNS must have been in place for at least 6 months prior to the Screening Visit Visit 1 with constant settings for at least 4-weeks prior to the Screening Visit Visit 1 and throughout the duration of the study 